Instil Bio (TIL) Net Cash Flow (2020 - 2026)

Instil Bio has reported Net Cash Flow for 7 years, with the latest figure at $649000.0 in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 107.63% year-over-year to $649000.0 in Q2 2026; TTM through Jun 2026 was -$2.0 million, a 296.36% decrease from a year earlier, with the FY2025 full-year figure at -$3.9 million, down 11769.7% from the prior year.
• Net Cash Flow was $649000.0 for Q2 2026 at Instil Bio, up from -$1.7 million in the prior quarter.
• The five-year high for Net Cash Flow was $23.2 million in Q1 2022, with the low at -$18.1 million in Q2 2022.
• Average Net Cash Flow over 5 years is -$1.7 million, with a median of -$471000.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow slumped 1523.27% in 2023, then surged 609.49% in 2024.
• Over 5 years, Net Cash Flow stood at $2.0 million in 2022, then sank by 71.94% to $569000.0 in 2023, then soared by 609.49% to $4.0 million in 2024, then tumbled by 81.62% to $742000.0 in 2025, then slipped by 12.53% to $649000.0 in 2026.
• The last three Net Cash Flow figures came in at $649000.0 (Q2 2026), -$1.7 million (Q1 2026), and $742000.0 (Q4 2025), per Business Quant data.